Epirium Bio
Phase 2Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $201M
About
Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Small Molecules
Funding History
2Total raised:$201M
Series B$116MJan 15, 2021
Series A$85MAug 15, 2019